Voltage-gated calcium channel (neuronal subtype) (CaV (often followed by subtype, e.g., CaV1.2, CaV2.1, etc.))

Neuronal calcium channels are transmembrane proteins forming ion-selective pores activated by voltage changes, allowing calcium entry into neurons. This influx is crucial for synaptic transmission, neuronal firing, gene regulation, and other specialized cellular processes. They are molecular complexes typically composed of an α1 pore-forming subunit—which determines the channel subtype (L-type, N-type, P/Q-type, R-type, T-type)—and accessory subunits (α2δ, β, γ) that modulate channel function and localization. Distinct VGCC subtypes differ in activation properties, tissue distribution, pharmacological sensitivity, and disease associations. Drugs targeting these channels are clinically important for pain management, epilepsy, hypertension, and emerging CNS indications. The term "neuronal calcium channel" refers to a molecularly and functionally heterogeneous group rather than a single entity, and therapeutic targeting demands precise subtype identification.

Other names

Neuronal VGCCVoltage-gated calcium channel (neuronal)CaV channelCalcium channel (neuronal)L-type, N-type, P/Q-type, R-type, T-type calcium channel (subtypes)

Direct channel blockade (by peptide toxins, synthetic drugs); Modulation of channel trafficking and gating (gabapentinoids); Reduction of calcium influx, leading to decreased neurotransmitter release, reduced neuronal excitability, and various downstream effects